Intraoperative MRI Equipment Market

Intraoperative MRI Equipment Market Outlook (2025 to 2035)

The intraoperative MRI equipment market size will be USD 1,220 million in 2025. Fact MR's research shows that the intraoperative MRI equipment market will rise at a rate of 8.5% CAGR and reach USD 2,770 million by 2035. The industry's growth is chiefly fueled by increasing cases of complex neurosurgical procedures that necessitate real-time accuracy imaging, which is something intraoperative MRI (iMRI) systems can uniquely provide.

In addition, increased hospital investments in advanced imaging suites and the movement towards minimally invasive surgeries are fueling the demand for such high-end diagnostic equipment. Intraoperative MRI equipment is an integral component of advanced operating rooms, especially in neurology and oncology departments.

MRI systems allow surgeons to update imaging in the course of the procedure, improving precision, reducing the likelihood of reoperation, and improving patient outcomes. Hospitals and operating facilities are seeking to integrate these systems to facilitate better real-time decision-making.

The market force is further driven by technological advancements, and advances in the capabilities of miniaturized low-field MRI systems are broadening the intraoperative application of this technology across middle-range hospitals. Next-generation equipment such as these improves flexibility and image quality and reduces infrastructural needs. Robotics-assisted procedures with iMRI guidance are also becoming the clinical standard in higher-rated institutions, enabling further penetration.

Regionally, North America is the current leader, underpinned by high health spending and early adoption of image-guided surgery systems. The Asia-Pacific is catching up quickly, however, with China, India, and South Korea's hospital modernization initiatives fueling robust growth trends. Surgical effectiveness and postoperative accuracy are of concern to these markets, and thus, iMRI integration is a key investment imperative.

In the next few years, stakeholders are expected to emphasize system miniaturization, cost minimization, and compatibility with digital surgery platforms. With the global volume of surgery set to grow further, intraoperative MRI technology will move from specialist to mainstream, from innovation as a function of capital needs to scalability of clinical benefits.

Key Metrics

Metric	Value
Estimated Global Size in 2025	USD 1,220 Mn
Projected Global Size in 2035	USD 2,770 Mn
CAGR (2025 to 2035)	8.5%

Fact.MR Survey Results: Industry Dynamics Based on Stakeholder Perspectives

Key Priorities of Stakeholders

• Surgical Accuracy & Real-Time Monitoring: 81% of stakeholders identified the ability to perform intraoperative scans as a critical factor for enhancing surgical precision and reducing postoperative complications.
• System Integration & Workflow Efficiency: 77% emphasized the need for seamless integration of iMRI systems into existing surgical workflows and digital surgery platforms.
• Operational Cost vs. Patient Outcome: 69% of hospital administrators cited improved patient outcomes as justification for high upfront costs, especially in neurosurgical and oncological applications.

Regional Variance:

• North America: 75% of hospitals prioritized full-suite hybrid operating rooms, combining iMRI with robotic and navigation technologies.
• Europe: 79% focused on optimizing throughput with faster scan-to-surgery transitions to minimize OR time.
• Asia-Pacific: 66% highlighted infrastructure upgrades as a major focus to support the growing demand for intraoperative imaging in tier-2 urban centers.

Adoption of Advanced Technologies

Technological Transformation:

• North America: 62% of institutions adopted AI-supported image reconstruction for faster real-time MRI interpretation.
• Europe: 57% invested in low-field portable MRI systems to enable flexible OR configurations.
• Asia-Pacific: 39% focused on hybrid imaging solutions that integrate with surgical navigation platforms.

Convergent vs. Divergent ROI Expectations:

• 72% of North American stakeholders view iMRI as a transformative ROI asset due to reduced reoperation rates. In comparison, only 49% of European stakeholders consider the technology viable for broad-scale adoption due to high CAPEX.

Supply Chain & Infrastructure Challenges

Common Challenges:

• 71% of stakeholders cited high facility renovation costs as a key barrier to adoption.

Regional Variance:

• Europe: 60% reported delays in installation timelines due to regulatory and compliance reviews.
• Asia-Pacific: 65% indicated limited access to trained installation and support personnel.
• North America: 69% faced procurement backlogs due to high system customization requirements.

Future Investment Priorities

Global Alignment:

• 74% of stakeholders plan to increase investments in compact and modular iMRI systems to reduce installation barriers.

Regional Focus:

• North America: 66% prioritized AI-integrated platforms to support intelligent surgical planning.
• Europe: 63% focused on investing in fast-installing MRI pods to enhance OR flexibility.
• Asia-Pacific: 59% emphasized affordability and localization strategies for scalable iMRI deployment.

Conclusion: Variance vs. Consensus

Broad Consensus:

• iMRI is recognized globally as a key enabler for surgical precision and clinical efficiency.

Regional Variance:

• North America: Emphasis on smart OR integrations and predictive analytics.
• Europe: Demand for flexible, faster-deployable imaging systems.
• Asia-Pacific: Prioritization of infrastructure and workforce scaling.

Strategic Insight:

• Stakeholders must localize their iMRI deployment strategies, aligning investments with regional readiness, workforce training, and system scalability.

Impact of Government Regulation

Country	Regulations & Impact on Intraoperative MRI Equipment
U.S.	Strong FDA oversight; mandates full clinical validation for intraoperative use, delaying rollout but ensuring reliability.
European Union	Strict imaging and magnetic field safety compliance hinder market penetration, particularly in smaller hospitals.
China	Fast-tracked hospital modernization policies driving adoption in urban and provincial centers.
Japan	Government subsidies are available for high-end medical imaging tools in teaching hospitals.
South Korea	Regulated integration into smart hospital infrastructure is accelerating iMRI inclusion in next-gen ORs.
India	Lack of clear imaging integration policies slows adoption outside Tier-1 cities.
UK	Cost constraints and emphasis on multi-use diagnostic assets limit NHS-led adoption.

Market Analysis

The intraoperative MRI equipment market is expanding steadily, fueled by the increasing demand for precision imaging in high-stakes surgical procedures. The key driver is the clinical push toward real-time intraoperative decision-making. Leading beneficiaries include large tertiary hospitals, while smaller clinics may struggle to justify costs without broader health policy incentives.

Top 3 Strategic Imperatives for Stakeholders

Expand Regulatory and Compliance Readiness

Executives should prioritize investments in regulatory alignment and certification processes to accelerate commercial adoption. Engaging with policymakers and industry bodies will help streamline approvals, ensuring seamless integration of iMRI into operating rooms.

Leverage AI, 5G, and Workflow Automation for Clinical Efficiency

Integrating AI-powered image interpretation, 5G-enabled data transfer, and workflow optimization tools will improve procedural outcomes and reduce time in the OR. Alignment with smart surgery platforms is key to long-term operational efficiency.

Strengthen Infrastructure and Training Ecosystems

Collaborating with imaging OEMs, hospital planners, and academic institutions will accelerate the development of installation-ready iMRI solutions. Investments in clinician training and support networks will reinforce sustainable deployment.

Top 3 Risks Stakeholders Should Monitor

Risk	Probability & Impact
High Capital Expenditure Requirements	High probability; limits mid-market and APAC adoption.
Regulatory Delays in System Deployment	Moderate probability impedes time-to-market.
Workforce Shortages in Imaging Specialties	High impact; slows clinical integration post-purchase.

Executive Watchlist

Priority	Immediate Action
OR Infrastructure Compatibility	Conduct gap analysis of existing OR facilities for iMRI retrofitting.
Training and Operational Readiness	Develop cross-functional training modules for imaging and surgical teams.
Vendor-Partner Strategy	Secure partnerships with imaging OEMs and system integrators.

For the Boardroom

To stay ahead, the companies must accelerate regulatory engagement, integrate AI and 5G for frictionless surgical operations, and leverage strategic partnerships to enable modular, infrastructure-agnostic deployments.

Fact.MR analysis concluded that the next wave of growth would be centered around compact iMRI innovation, which would be able to fit mid-sized ORs with limited reconstruction. Success would depend on hardware coordination with AI-driven surgical platforms and clinical decision support systems. Early adopters investing in OR-smart design, clinician education, and regional distribution frameworks will be leaders in precision-guided surgery.

Intraoperative MRI will no longer be a luxury of elite hospitals-the marketplace is now set to transform surgical imaging standards globally.

Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035

During 2020-2024, the intraoperative MRI equipment market accelerated, with neurosurgery units increasingly placing priority on accuracy and real-time imaging to achieve improved outcomes in surgery. For example, American hospitals like Brigham and Women's and Zurich's University Hospital adopted high-resolution intraoperative MRI to provide greater brain tumor resection and minimize residual tumor tissue.

This period saw the combination of iMRI with neuronavigation systems, enabling surgeons to perform intraoperative corrections while performing complex procedures like glioma resection or pituitary tumor resection. Moreover, leading manufacturers started integrating imaging software directly into the surgical console, which improved workflow efficiency.

From 2025-2035, the intraoperative MRI equipment market will witness significant innovations like AI-assisted imaging interpretations and transportable iMRI units. For example, top-tier imaging firms have collaborated with health tech firms to co-engineer mobile MRI systems appropriate for mid-range surgical centers.

In Southeast Asia and Latin America, investments in healthcare infrastructure are projected to drive the installation of less expensive, low-field iMRI units within public facilities. These patterns indicate a democratization of sophisticated surgical imaging technology across geographies and income segments.

Comparative Market Shift Analysis: Intraoperative MRI Equipment Market

2020 to 2024	2025 to 2035
Mainly neurosurgery, spinal tumor resection	Extended to cardiovascular and gastrointestinal interventions
High-quality imaging, convergence with neuronavigation	AI-interpreted interpretations, transportable iMRI equipment
Increased surgeries for the brain and spine; need for accuracy	Drive to surgical efficiency, decentralization of health technology
Concentrated in North America and European tertiary hospitals	Extension into emerging nations through modular, scalable equipment
Fixed, room-scale systems in dedicated operating rooms	Small, portable designs for deployment in ASCs and community hospitals
Alliances between device OEMs and hospitals for workflow integration	Alliances between MedTech companies and AI startups for smart diagnostics

Country-wise Analysis

Country	CAGR (2025 to 2035)
U.S.	8.1%
UK	6.8%
France	6.5%
Germany	7.2%
Italy	6.3%
South Korea	7.4%
Japan	6.9%
China	8.6%
Australia-NZ	6.7%

The U.S.

The U.S. intraoperative MRI equipment market is anticipated to grow at 8.1% CAGR during the forecast period. The country's well-developed healthcare infrastructure is one of the major drivers for the deployment of intraoperative MRI systems. Large public and private investments in neurosurgical departments raise the prospects of industry penetration.

With the ever-growing surgical need for real-time imaging, particularly for spine and brain surgery, intraoperative MRI systems are becoming a common fixture in operating room facilities. Funding for research and favorable reimbursement policies stimulate purchasing and innovation in the field.

Having key manufacturers and research centers available facilitates bringing high-accuracy imaging systems into the local industry sooner. There is increased awareness and education among operating personnel as well, which leads to operational performance and outcomes through intraoperative imaging.

In addition, the comparatively high proportion of advanced surgeries and early adoption of new medical technology put the U.S. in a preeminent position within the international intraoperative MRI equipment market. Overall, the U.S. market is based on a robust foundation for technological integration, thus suited best to intraoperative MRI solutions within the next decade.

UK

The UK intraoperative MRI equipment market is expected to grow at 6.8% CAGR during the period of study. The country's increasing focus on optimizing surgical outcomes with the assistance of sophisticated imaging systems is positively impacting the adoption of intraoperative MRI machines.

The National Health Service (NHS) has shown strategic interest in embracing real-time imaging technology to optimize resource utilization and reduce postoperative complications. These efforts are contributing to the consistent but incremental growth in equipment installations in top healthcare facilities.

Although the adoption rate is moderate compared to larger industries, the UK has a centrally managed healthcare model that facilitates policy standardization and technological standardization. Investment in surgical innovation centers and collaborations with academic medical centers also enhance research and integration of advanced imaging modalities.

Further, steady growth in advanced neurosurgical interventions and growing demands for minimally invasive treatments are driving the value proposition for intraoperative MRI systems. As acquisition policies become increasingly biased towards precision-guided solutions, the UK is poised to transform step by step through the forecast period.

France

The French intraoperative MRI equipment market is predicted to develop at 6.5% CAGR during the study period. France is committed to upgrading its operating room equipment, with intraoperative MRI units serving as a driving force in support of precision-based neurosurgical and oncological procedures.

Academic medical centers and regional centers are upgrading to incorporate real-time intraoperative imaging, driven by attempts to eliminate post-surgery relapse and complications. Regulatory and financial constraints have been a longstanding impediment to technology adoption at a rapid pace; however, new strategic healthcare reforms have included funds for digitalization and modernization of hospitals.

This transition is enabling greater access to intraoperative MRI and high-end imaging technology. Also, the country's emphasis on surgical excellence through public-private collaborative research is enhancing innovation and solutions at the local level as per European standards.

The steady expansion of oncology and neurology departments in tertiary care hospitals also supports the demand outlook. Overall, France is poised for robust growth, led by policy change and a clinically driven emphasis on surgery with imaging.

Germany

The German intraoperative MRI equipment market will expand at 7.2% CAGR during the study period. With one of Europe's most advanced technology healthcare systems, Germany is the ideal location for the introduction of intraoperative MRI machines.

A leader in the adoption of precision medicine methods, Germany sees intraoperative imaging in real-time becoming an absolute necessity for success in clinical applications across neurology, oncology, and orthopedics specialties. German healthcare facilities are underpinned by substantial investment in infrastructure, and therefore, integration of advanced imaging technologies with operating rooms becomes increasingly feasible.

The best hospitals and medical schools have a keen interest in pilot projects and clinical trials based on intraoperative MRI. They are, therefore, also held accountable for proving its effectiveness and economic feasibility. In addition, frequent incidence of brain and spine surgeries along with the aging population supports continuous development of demand. Germany's robust local production infrastructure and transparent regulation also add to constant development during the forecast period.

Italy

The Italian intraoperative MRI equipment market will develop at a 6.3% CAGR during the study period. Italy's intraoperative MRI equipment market is characterized by a greater emphasis on creating surgical potential at both private and public healthcare facilities.

Even though adoption has been delayed due to considerations of cost along with geographical variation in the healthcare infrastructure base, there are urban hospitals that have implemented programs for integrating intraoperative imaging into specialty operating rooms.

Rome's clinical centers and medical schools, as well as those in Milan and Florence, are taking the lead as early adopters facilitated by EU-source funding programs and technology upgrade grants. Increased focus on neurosurgery and brain tumor therapy has driven intraoperative MRI system demand, particularly as a tool for improved accuracy and diminished residual tumor volume.

As surgical departments grow more inclined toward minimally invasive and image-guided surgeries, Italy will reflect sluggish but notable growth. The concerted efforts of public health authorities and medical device makers will further establish the adoption curve in the years to come.

South Korea

South Korea's intraoperative MRI equipment market is expected to grow at 7.4% CAGR during the study period. South Korea keeps pace with rapid advancement in adopting surgical technology by virtue of healthcare programs encouraged by the government and an environment that favors innovation.

Large hospital centers in Seoul and Busan embrace intraoperative MRI as soon as possible, and integration is facilitated by robust IT infrastructure and electronic health systems. The country's high volume of neurosurgical procedures, along with an increasingly afflicted population by neurological disease, underscores strong clinical demand.

In addition, emphasis on medical tourism and hospital accreditation has prompted many institutions to upgrade facilities with next-generation imaging equipment for surgery. Local suppliers and manufacturers are also critical to providing local demand with cost-effective substitutes.

Continuous education and specialist training modules for surgical staff support expanded application and long-term viability of intraoperative MRI devices in clinical settings. South Korea is thus strategically positioned for growth by strong corporations driven by technology sensitivity and facilitating policy environment.

Japan

The Japanese intraoperative MRI equipment market is projected to achieve a 6.9% CAGR over the forecast period. Japan's aging population and the resultant rise in neurological and chronic ailments have spurred demand for accurate surgical solutions such as intraoperative MRI systems. Strong emphasis on technology diligence and clinical excellence, with top Tokyo, Osaka, and Nagoya hospitals leading the industry, are embracing cutting-edge imaging systems within hybrid operating theaters.

Where financial concerns in rural and smaller hospitals are a limitation, giant academic institutions are taking the lead with enormous investments in oncology and neurosurgery departments. Cooperative research between clinical facilities and technology suppliers is enhancing equipment localization and efficiency.

The direction toward minimally invasive and robotically assisted procedures also supports the integration of intraoperative MRI systems. Japan's regulatory transparency and stable reimbursement environment give additional confidence to equipment suppliers, highlighting its status as a reliable and innovation-promoted region.

China

China's intraoperative MRI equipment market is expected to post an 8.6% CAGR during the forecast period. China is home to the most dynamic intraoperative MRI equipment market in Asia as a result of comprehensive healthcare infrastructure expansion and increased penetration of healthcare services in urban as well as semi-urban cities. Substantial investment in third-level care hospitals and specialty surgical centers has presented opportunities for augmented application of premium intraoperative imaging technology.

The healthcare reforms promoted by the government focus on high-quality treatment and real-time diagnostic capability, and they spearheaded the deployment of intraoperative MRI systems. Furthermore, a high incidence of brain and spine tumors, together with a strategic focus on technology-enabled precision medicine, fuels strong clinical demand.

Local firms are increasingly entering the premium medical device segment, creating improved affordability and industry access. With growing awareness, clinical training, and favorable policy frameworks, the Chinese intraoperative MRI equipment market will lead in adoption volume, establishing regional benchmarks in intraoperative MRI integration.

Australia-New Zealand

The Australia-New Zealand intraoperative MRI equipment market is expected to grow at 6.7% CAGR during the period of the study. The region has a highly developed healthcare system and a rising emphasis on the precision of surgery, both contributing to the growing demand for intraoperative MRI equipment. Major hospitals and academic institutions across Sydney, Melbourne, and Auckland are incorporating intraoperative imaging into neurosurgical and oncology units.

The industry size is small in the Australia-New Zealand region. The willingness to adopt sophisticated medical technologies and conduct evidence-based appraisals underlies strong industry growth. Government and private financing programs are compelling infrastructure improvements and equipment capital purchases.

Besides, cross-border collaborations with Southeast Asian countries and medical tourism add to the region's strategic value. The steady increase in surgical services and the availability of skilled personnel will most likely translate to long-term intraoperative MRI adoption growth in the area.

Segment-wise Analysis

By Product Type

By product type, the intraoperative MRI equipment market is anticipated to be led by the 0.2T systems and 3.0T systems, which together form the bulk of the global industry. The revenue share for the 0.2T system is projected to be around 40%. In comparison, the 3.0T system will closely follow with a 38% share, signifying differences in the choice of imaging modality in surgical environments based on considerations such as infrastructure and cost.

Low-field MRI systems are 0.2T systems that have gained popularity mainly due to their cost efficiency, less energy consumption, and minimal requirements in terms of infrastructure. These facilities are of strategic importance because 0.2T systems generally find use in small hospitals and surgical centers, where budget and space constraints weigh heavily.

Compact and mobile 0.2T iMRI units have been produced by Hitachi Medical Systems and Esaote, which are affordable and provide sufficient imaging support during procedures such as neurosurgery and orthopedics without costly and time-consuming alterations to facility layouts. The ability of 0.2T to deliver real-time intraoperative imaging at a lower operational cost helps to maintain its presence, especially in emerging economies.

3.0T systems, which are known for their high resolution, are the preferred systems for advanced surgical applications, particularly in academic medical centers and high-volume departments dedicated to neurosurgical operations. High-field systems provide clinical superiority as far as soft tissue contrast and anatomical detail are concerned, with highly critical procedures such as brain tumor resections and functional neurosurgeries.

Key leaders, both in the iMRI segment and those that integrate their 3.0T hardware into the latest surgical navigation platforms, include Siemens Healthineers, GE Healthcare, and Philips Healthcare. These systems command heavy financial requirements as well as specialized infrastructure. Still, their benefits in clinical terms drive adoption in highly technologically advanced health systems in North America and Western Europe.

It reflects the balance between accessibility and performance since both systems still serve various clinical and operational requirements across the expanding intraoperative MRI space.

By End User

By end-use, hospitals account for around 40% of the share, whereas cancer research institutes hold around 25%.

Hospitals account for the highest share by 40%, mediated by the integration of iMRI systems into operating theatres for neurosurgery, spinal surgery, and orthopedic procedures. So, the use of iMRI makes surgeons visualize the surgical field intraoperatively, which in turn reduces reoperations and improves surgical outcomes.

Some of the leading medical institutions, the Cleveland Clinic, Mayo Clinic, and Charité - Universitätsmedizin Berlin, are using state-of-the-art suites equipped with an iMRI to aid in image-guided interventions. The preference for iMRI in hospitals is also being helped by the increasing demand for minimally invasive and high-precision surgeries, especially in regions with aging populations and, subsequently, higher neurological disorders.

Cancer research institutes are expected to hold a revenue share of 25%, as iMRI plays an important role in supporting tumor resections and experimental oncologic procedures. In particular, where high magnetic field systems (like 3.0T) are concerned, the use of intraoperative MRI for better visualization of the margins of the tumor has a great benefit for oncologic surgeons since it can help obtain more complete resections and, therefore, minimize critical injury to vital surrounding tissues.

MD Anderson Cancer Center and Dana-Faber Cancer Institute are doing iMRI for the treatment of various brain, spinal, and prostate cancers. The use of iMRI, along with real-time navigation systems and intraoperative pathology, enriches the surgical plan and decision-making intraoperatively in the setting of cancer treatment.

The ground adoption of iMRI technology at hospitals and cancer research institutions reflects the broader foundation for the increased emphasis on precision medicine, surgical accuracy, and patient safety extending across different medical disciplines.

Competitive Outlook

The industry is full of competitive giants in medical imaging technology developments, working on system integration and attaining real-time precision in surgical imaging. These strong players give priority to high-field MRI systems, neuronavigation integration, and improvements in AI imaging, which are majorly needed by the disciplines of neurosurgery, oncology and orthopedics.

The intraoperative MRI solutions, 3.0T and 1.5T, from GE Healthcare and Siemens AG, respectively, cater to efficient high-resolution imaging with seamless control over real-time surgical guidance integrated easily in the general operating room. Their prolonged partnerships with hospitals and research collaborations have helped maintain their position in the industry.

Medtronic Plc and Koninklijke Philips N.V.'s neurosurgical MRI innovations have made inroads into AI-driven imaging analytics and robotic-assisted visualization tools that could enhance precision during brain tumor and epilepsy surgeries. Their pioneering thrust towards minimally invasive procedures and workflow efficiency is cutting edge.

Hitachi Ltd. & Toshiba Corporation (joined Canon Medical Systems) stand out as cost-effective solutions for open-bore iMRI targeting small and medium hospitals and specialty surgical centers. This compact design and low operational costs would surely benefit an institution with limited space and financial constraints.

IMRIS, Inc. sets itself apart with completely integrated hybrid OR solutions, enabling multi-disciplinary surgical teams to access MRI without relocating the patient and resulting in a tremendous increase in patient safety and surgical flow efficiency.

Market Share Analysis by Company

Company Name	Estimated Market Share (%)
General Electric Company	24-28%
Siemens AG	20-24%
Medtronic Plc	15-19%
Koninklijke Philips N.V.	12-16%
Hitachi Ltd. / Toshiba Corporation	8-12%
Other Companies (combined)	15-21%

Key Company Offerings and Activities

Company Name	Key Offerings/Activities
General Electric Company	High-field 3.0T iMRI systems with AI-driven imaging analytics for neurosurgical applications.
Siemens AG	Integrated neuronavigation with 1.5T and 3.0T MRI solutions for high-precision intraoperative imaging.
Medtronic Plc	Advanced MRI-compatible surgical tools and imaging systems for precision-guided neurosurgery.
Koninklijke Philips N.V.	AI-enhanced imaging solutions with real-time surgical feedback and automated tumor detection.
Hitachi Ltd. / Toshiba Corporation	Open-bore iMRI systems for cost-effective real-time imaging in surgical procedures.

Key Company Insights

General Electric Company (24-28%)

GE Healthcare leads the industry with its 3.0T Signa system, integrating deep learning-based imaging enhancement and seamless OR connectivity, ensuring real-time decision-making.

Siemens AG (20-24%)

Siemens is at the forefront of neuronavigation integration, with advanced MR-compatible robotic guidance, enabling high-precision brain and spine surgeries.

Medtronic Plc (15-19%)

Medtronic’s StealthStation MRI-guided surgical systems enhance tumor resection accuracy, focusing on minimally invasive neurosurgical procedures.

Koninklijke Philips N.V. (12-16%)

Philips combines AI-driven diagnostics and real-time OR feedback, optimizing imaging accuracy for neurosurgery and interventional oncology.

Hitachi Ltd. / Toshiba Corporation (8-12%)

Hitachi and Toshiba offer affordable iMRI solutions, targeting smaller hospitals and surgical centers with compact, cost-effective imaging systems.

Key Players

• General Electric Company
• Siemens AG
• Medtronic Plc
• Koninklijke Philips N.V.
• Hitachi Ltd. / Toshiba Corporation
• IMRIS, Inc.

Segmentation

• By Product Type :

  • 0.2T System
  • 1.5T System
  • 3.0T System
  • Others

• By End User :

  • Hospitals
  • Cancer Research Institutes
  • Academic Institutes
  • Other End Users

• By Application :

  • Neurosurgical Intervention
  • Orthopedic Procedures
  • Cardiovascular Intervention
  • Other Applications

• By Region 

  • North America
  • Latin America
  • Europe
  • APEJ (Asia-Pacific excluding Japan)
  • MEA (Middle East & Africa)